Business
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024Amgen expands global Growth Direct system rollout with significant multi-system order in the fourth quarter 2025; will sponsor North American Growth Direct Day in the second quarter 2026Samsung Biologics continues to expand Growth Direct deployment across its manufacturing network w
About this update from Amgen Inc.
[{"type":"image","alt":"Rapid Micro Biosystems, Inc.","displaySize":"","headline":null,"caption":"Rapid Micro Biosystems, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":155,"url":"https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t0NXhkXriNft2AMfxGKlHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0","width":300,"height":155}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024","length":127,"tagName":"p"}]},{"val":[{"type":"text","content":"Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024","length":100,"tagName":"p"}]},{"val":[{"type":"text","content":"Amgen expands global Growth Direct system rollout with significant multi-system order in the fourth quarter 2025; will sponsor North American Growth Direct Day in the second quarter 2026","length":186,"tagName":"p"}]},{"val":[{"type":"text","content":"Samsung Biologics continues to expand Growth Direct deployment across its manufacturing network with a meaningful multi-system order in the first quarter 2026","length":158,"tagName":"p"}]},{"val":[{"type":"text","content":"For the full year 2026, the Company expects total revenue in the range of $37.0 million to $41.0 million including a range of 30 to 38 Growth Direct system placements and gross margin percentage of approximately 20%","length":215,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":786,"olType":false},{"type":"text","content":"LEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2025.","length":397,"tagName":"p"},{"type":"text","content":"“We closed 2025 with significant momentum, delivering 20% year-over-year revenue growth,” said Robert Spignesi, President and CEO. “Our performance was highlighted ...